Tenders

Roof Sealing Work for Apartment Building Wio 1+2

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Erythropoietin (Exclusively Epoetin Zeta), (Obo), Atc B03xa01 for the Period December 1St, 2024 - November 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Elafibranor (Obo), Atc A05ax06 for the Period December 1St, 2024 - November 30Th, 2026

Mobile TSCIF (x2); EUCOM AoR

Regular Non-Binding Announcement about the Shortening of the A&I Deadline

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Regular Non-Binding Announcement about the Shortening of the Sbad Deadline

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredients Dienogest and Estrogen (G03fa15) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Iron(Iii) Sodium Gluconate Complex (B03ac07) as Part of a So-Called Open House...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Ertugliflozin (A10bk04) as Part of a So-Called Open House Model.